The Duke Center for Neurodegeneration and Neurotherapeutics (DCNN) is made of an interdisciplinary team of experts from across Duke that works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development. Read more about the DCNN and its work here.| neurology.duke.edu
The Sanders Lab studies Parkinson’s disease (PD), the most common neurodegenerative movement disorder. Even with expert treatment, PD patients typically deteriorate over time and endure considerable motor and non-motor disability. There are no disease modifying therapies, thus, this is an urgent unmet medical need. We take a translational approach (i.e. bench-to-bedside), aiming to translate our multidisciplinary basic scientific research into meaningful health outcomes for PD patients. To ...| neurology.duke.edu